Ferring Pharmaceuticals is pleased to announce that the Ferring Innovation Grants Portal is now open and accepting applications. The goal of the Ferring Innovation Grants program is to fund projects designed to identify novel drug targets that are:
- For indications within their core therapeutic areas (Reproductive Health, Urology, Gastroenterology)
- Addressable with peptides and/or proteins
- Exploratory, discovery and/or preclinical in nature
The program will provide a limited number of grants in the amount of $50,000. The grants DO NOT carry indirect costs and are not renewable. Funding will not be provided for clinical studies, studies which require collection of patient biopsies or studies to develop small molecules. In all cases the intellectual property rights remain with the applicant.
Application Deadline: July 1st, 2015
For more information visit the Ferring Pharmaceuticals webpage.
Clinical & Translational Science Collaborative – Career Development Training Opportunity
The Clinical & Translational Science Collaborative (CTSC) KL2 a post-doctoral training program with an emphasis on multidisciplinary clinical and translational research, offers an innovative career development opportunity for qualified candidates.
The CTSC KL2 is designed to train the nation’s future leaders in clinical and translational research, and is part of the NIH Roadmap aimed at “re-engineering the clinical research enterprise.” The CTSC KL2 has just welcomed this year’s cohort of scholars, who were selected from a highly competitive pool of applicants:
- Mohamed Abazeed, MD, PhD (Radiation Oncology; Translational Hematology & Oncology, CCF)
- Stefanie Avril, MD (Pathology, CWRU)
- Nicholas Schiltz, PhD (Epidemiology & Biostatistics, CWRU)
- Jennifer Sweet, MD (Neurosurgery, University Hospitals Case Medical Center)
CTSC KL2 is now seeking applications for next year’s cohort.
Qualified candidates must:
- Hold an MD, PhD, DDS, PharmD, PsyD, or equivalent degree
- Demonstrate a keen interest in clinical research
- Have an appointment in one of the CTSC partner institutions on or before July 1, 2016
- Be a U.S. citizen or have permanent resident status
Each scholar will embark on a 4-year program of intensive training in multidisciplinary team-based, patient-oriented clinical research, combining an innovative curriculum with mentored research experiences.
Applications will be accepted between 7/1/15 and 10/12/15.
For more information, contact Beth Spyke, MPA, at email@example.com / 216.444.2702 or Raed Dweik, MD, at firstname.lastname@example.org / 216-445-5763. You may also request to schedule an information session.
For additional information, visit the CTSC webpage.
2014 COI Disclosure Status Reflected in Sparta System
The deadline for submission of CWRU 2014 Outside Interests Disclosure forms was April 1, 2015. The Sparta System reflects those who have submitted their 2014 disclosure to the Conflict of Interests (COI) Office.
Please be aware, however, that if individuals listed as key personnel on proposals in Sparta have not completed the 2014 Outside Interests Disclosure process, those individuals will need to do so before proposals can continue in the approval workflow. It is important to allow enough time to address any instances of overdue disclosures when submitting a proposal.
For assistance with the disclosure process or any questions, contact the staff of the Conflict of Interests Office at 216-368-0838 or 216-368-5963 (email@example.com).
Department of Defense
The Department of Defense has announced the following new funding opportunities:
Department of the Army - USAMRAA
DoD Gulf War Illness Innovative Treatment Evaluation Award
DoD Gulf War Illness Clinical Trial Award
DoD Gulf War Illness Epidemiology Research Award
DoD Gulf War Illness Investigator-Initiated Research Award
DoD Gulf War Illness New Investigator Research Award
NIH Posts Reminder of Its Policy on Application Compliance
The National Institutes of Health (NIH) recently released a notice to remind applicants, both investigators and grants office officials, that to be fair to all concerned the NIH needs to consistently apply standards for application compliance.
In part, the notice states that NIH may withdraw any application identified during the receipt, referral and review process that is not compliant with the instructions in the SF 424 (R&R) Application Guide, the Funding Opportunity Announcement, and relevant NIH Guide Notices.
Examples of reasons an application may be withdrawn for non-compliance include:
Read the full notice at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-095.html.
- inclusion of biosketchs that do not conform to the required format
- applications that do not conform to page limit requirements
- applications submitted as new but containing elements of a resubmission or renewal application
- applications submitted after 5 pm local time
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
firstname.lastname@example.org no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be